Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021

Loading...
Loading...

Upgrades

Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc INDP from Hold to Buy. Indaptus Therapeutics earned $5.53 in the second quarter. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Indaptus Therapeutics closed at $7.54.

Kepler Cheuvreux upgraded the previous rating for Credit Suisse Group AG CS from Hold to Buy. Credit Suisse Group earned $0.11 in the second quarter, compared to $0.48 in the year-ago quarter. The current stock performance of Credit Suisse Group shows a 52-week-high of $14.95 and a 52-week-low of $9.28. Moreover, at the end of the last trading period, the closing price was at $10.45.

According to Wolfe Research, the prior rating for WEC Energy Group Inc WEC was changed from Underperform to Peer Perform. WEC Energy Gr earned $0.87 in the second quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of $106.85 and a 52-week-low of $80.55. At the end of the last trading period, WEC Energy Gr closed at $88.84.

According to Evercore ISI Group, the prior rating for Macerich Co MAC was changed from Underperform to In-Line. In the second quarter, Macerich showed an EPS of $0.59, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.99 and a 52-week-low of $6.42. Macerich closed at $18.15 at the end of the last trading period.

According to Barclays, the prior rating for argenx SE ARGX was changed from Equal-Weight to Overweight. For the second quarter, argenx had an EPS of $1.98, compared to year-ago quarter EPS of $3.15. At the moment, the stock has a 52-week-high of $382.15 and a 52-week-low of $244.98. argenx closed at $291.93 at the end of the last trading period.

Barclays upgraded the previous rating for Shell Midstream Partners LP SHLX from Equal-Weight to Overweight. Shell Midstream Partners earned $0.36 in the second quarter, compared to $0.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.50 and a 52-week-low of $8.17. Shell Midstream Partners closed at $11.81 at the end of the last trading period.

According to Morgan Stanley, the prior rating for Xcel Energy Inc XEL was changed from Underweight to Equal-Weight. For the second quarter, Xcel Energy had an EPS of $0.58, compared to year-ago quarter EPS of $0.54. The current stock performance of Xcel Energy shows a 52-week-high of $76.44 and a 52-week-low of $57.23. Moreover, at the end of the last trading period, the closing price was at $64.68.

For Eversource Energy ES, Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. For the second quarter, Eversource Energy had an EPS of $0.79, compared to year-ago quarter EPS of $0.76. The current stock performance of Eversource Energy shows a 52-week-high of $96.66 and a 52-week-low of $76.64. Moreover, at the end of the last trading period, the closing price was at $85.41.

For Pearson PLC PSO, Berenberg upgraded the previous rating of Sell to Hold. The stock has a 52-week-high of $12.38 and a 52-week-low of $6.38. At the end of the last trading period, Pearson closed at $8.52.

For Albemarle Corp ALB, RBC Capital upgraded the previous rating of Sector Perform to Outperform. In the second quarter, Albemarle showed an EPS of $0.89, compared to $0.86 from the year-ago quarter. The current stock performance of Albemarle shows a 52-week-high of $253.09 and a 52-week-low of $90.07. Moreover, at the end of the last trading period, the closing price was at $236.91.

For Crown Castle International Corp CCI, Credit Suisse upgraded the previous rating of Neutral to Outperform. For the second quarter, Crown Castle Intl had an EPS of $1.71, compared to year-ago quarter EPS of $1.45. The current stock performance of Crown Castle Intl shows a 52-week-high of $204.62 and a 52-week-low of $146.15. Moreover, at the end of the last trading period, the closing price was at $167.81.

For SBA Communications Corp SBAC, Credit Suisse upgraded the previous rating of Neutral to Outperform. For the second quarter, SBA Communications had an EPS of $1.37, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $369.56 and a 52-week-low of $232.88. SBA Communications closed at $323.40 at the end of the last trading period.

RBC Capital upgraded the previous rating for Ranger Oil Corp ROCC from Sector Perform to Outperform. The stock has a 52-week-high of $32.48 and a 52-week-low of $8.78. At the end of the last trading period, Ranger Oil closed at $30.73.

For Diamondrock Hospitality Co DRH, Evercore ISI Group upgraded the previous rating of Underperform to In-Line. For the second quarter, Diamondrock Hospitality had an EPS of $0.05, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $11.48 and a 52-week-low of $4.68. At the end of the last trading period, Diamondrock Hospitality closed at $9.56.

See all analyst ratings upgrades.

Downgrades

According to Citigroup, the prior rating for Albertsons Companies Inc ACI was changed from Buy to Neutral. Albertsons Companies earned $0.64 in the second quarter, compared to $0.60 in the year-ago quarter. The current stock performance of Albertsons Companies shows a 52-week-high of $34.09 and a 52-week-low of $13.90. Moreover, at the end of the last trading period, the closing price was at $29.51.

Wedbush downgraded the previous rating for Zillow Group Inc ZG from Outperform to Neutral. In the second quarter, Zillow Gr showed an EPS of $0.44, compared to $0.41 from the year-ago quarter. The current stock performance of Zillow Gr shows a 52-week-high of $212.40 and a 52-week-low of $83.54. Moreover, at the end of the last trading period, the closing price was at $85.46.

Wolfe Research downgraded the previous rating for Fortis Inc FTS from Peer Perform to Underperform. Fortis earned $0.45 in the second quarter, compared to $0.40 in the year-ago quarter. The current stock performance of Fortis shows a 52-week-high of $47.02 and a 52-week-low of $38.49. Moreover, at the end of the last trading period, the closing price was at $45.46.

For Consolidated Communications Holdings Inc CNSL, Citigroup downgraded the previous rating of Neutral to Sell. For the second quarter, Consolidated Comms Hldgs had an EPS of $0.09, compared to year-ago quarter EPS of $0.21. The current stock performance of Consolidated Comms Hldgs shows a 52-week-high of $9.89 and a 52-week-low of $4.45. Moreover, at the end of the last trading period, the closing price was at $9.33.

According to Barclays, the prior rating for Holly Energy Partners LP HEP was changed from Overweight to Equal-Weight. For the second quarter, Holly Energy Partners had an EPS of $0.48, compared to year-ago quarter EPS of $0.40. The current stock performance of Holly Energy Partners shows a 52-week-high of $23.69 and a 52-week-low of $10.48. Moreover, at the end of the last trading period, the closing price was at $20.04.

According to Wolfe Research, the prior rating for Williams Companies Inc WMB was changed from Outperform to Peer Perform. For the second quarter, Williams Companies had an EPS of $0.27, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $29.89 and a 52-week-low of $18.26. At the end of the last trading period, Williams Companies closed at $29.29.

Wolfe Research downgraded the previous rating for Enterprise Products Partners LP EPD from Outperform to Peer Perform. In the second quarter, Enterprise Prods Partners showed an EPS of $0.50, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $25.69 and a 52-week-low of $16.01. At the end of the last trading period, Enterprise Prods Partners closed at $24.57.

According to Exane BNP Paribas, the prior rating for International Paper Co IP was changed from Outperform to Neutral. For the second quarter, International Paper had an EPS of $1.06, compared to year-ago quarter EPS of $0.77. The stock has a 52-week-high of $65.27 and a 52-week-low of $42.48. At the end of the last trading period, International Paper closed at $52.87.

According to Morgan Stanley, the prior rating for Kaleido Biosciences Inc KLDO was changed from Equal-Weight to Underweight. For the second quarter, Kaleido Biosciences had an EPS of $0.56, compared to year-ago quarter EPS of $0.59. The current stock performance of Kaleido Biosciences shows a 52-week-high of $20.50 and a 52-week-low of $4.75. Moreover, at the end of the last trading period, the closing price was at $4.85.

HC Wainwright & Co. downgraded the previous rating for Flexion Therapeutics Inc FLXN from Buy to Neutral. For the second quarter, Flexion Therapeutics had an EPS of $0.44, compared to year-ago quarter EPS of $0.76. The current stock performance of Flexion Therapeutics shows a 52-week-high of $13.66 and a 52-week-low of $4.30. Moreover, at the end of the last trading period, the closing price was at $9.31.

Evercore ISI Group downgraded the previous rating for Marriott International Inc MAR from Outperform to In-Line. Marriott Intl earned $0.79 in the second quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $161.42 and a 52-week-low of $88.92. Marriott Intl closed at $159.21 at the end of the last trading period.

Credit Suisse downgraded the previous rating for Esperion Therapeutics Inc ESPR from Outperform to Neutral. In the second quarter, Esperion Therapeutics showed an EPS of $1.67, compared to $4.32 from the year-ago quarter. The stock has a 52-week-high of $39.49 and a 52-week-low of $8.37. At the end of the last trading period, Esperion Therapeutics closed at $8.86.

Loading...
Loading...

See all analyst ratings downgrades.

Initiations

With a Equal-Weight rating, Morgan Stanley initiated coverage on Cue Health Inc HLTH. The price target seems to have been set at $12.00 for Cue Health. In the second quarter, Cue Health showed an EPS of $0.03, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Cue Health closed at $9.95.

With an Outperform rating, Barrington Research initiated coverage on StarTek Inc SRT. The price target seems to have been set at $8.00 for StarTek. StarTek earned $0.24 in the second quarter, compared to $0.07 in the year-ago quarter. The current stock performance of StarTek shows a 52-week-high of $9.80 and a 52-week-low of $4.95. Moreover, at the end of the last trading period, the closing price was at $5.63.

CLSA initiated coverage on Futu Holdings Ltd FUTU with a Buy rating. The price target for Futu Holdings is set to $110.00. Futu Holdings earned $0.45 in the second quarter, compared to $0.24 in the year-ago quarter. The stock has a 52-week-high of $204.25 and a 52-week-low of $29.30. At the end of the last trading period, Futu Holdings closed at $63.98.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Clearwater Analytics Holdings Inc CWAN. The price target seems to have been set at $26.00 for Clearwater Analytics Hldg. The current stock performance of Clearwater Analytics Hldg shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $25.11.

William Blair initiated coverage on Clearwater Analytics Holdings Inc CWAN with an Outperform rating. The current stock performance of Clearwater Analytics Hldg shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $25.11.

With a Buy rating, Berenberg initiated coverage on Churchill Downs Inc CHDN. The price target seems to have been set at $294.00 for Churchill Downs. In the second quarter, Churchill Downs showed an EPS of $3.08, compared to $0.53 from the year-ago quarter. The current stock performance of Churchill Downs shows a 52-week-high of $262.20 and a 52-week-low of $147.06. Moreover, at the end of the last trading period, the closing price was at $257.03.

With an Overweight rating, Wells Fargo initiated coverage on Clearwater Analytics Holdings Inc CWAN. The price target seems to have been set at $28.00 for Clearwater Analytics Hldg. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Clearwater Analytics Hldg closed at $25.11.

Credit Suisse initiated coverage on Clearwater Analytics Holdings Inc CWAN with an Outperform rating. The price target for Clearwater Analytics Hldg is set to $27.00. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Clearwater Analytics Hldg closed at $25.11 at the end of the last trading period.

With a Market Outperform rating, JMP Securities initiated coverage on Vor Biopharma Inc VOR. The price target seems to have been set at $40.00 for Vor Biopharma. Vor Biopharma earned $0.50 in the second quarter. The current stock performance of Vor Biopharma shows a 52-week-high of $63.62 and a 52-week-low of $11.78. Moreover, at the end of the last trading period, the closing price was at $14.76.

JMP Securities initiated coverage on Macrogenics Inc MGNX with a Market Outperform rating. The price target for Macrogenics is set to $39.00. For the second quarter, Macrogenics had an EPS of $0.66, compared to year-ago quarter EPS of $0.94. The stock has a 52-week-high of $36.48 and a 52-week-low of $18.16. At the end of the last trading period, Macrogenics closed at $19.74.

With a Neutral rating, Goldman Sachs initiated coverage on Clearwater Analytics Holdings Inc CWAN. The price target seems to have been set at $23.00 for Clearwater Analytics Hldg. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Clearwater Analytics Hldg closed at $25.11.

With a Buy rating, Goldman Sachs initiated coverage on Cue Health Inc HLTH. The price target seems to have been set at $19.00 for Cue Health. For the second quarter, Cue Health had an EPS of $0.03, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Cue Health closed at $9.95.

Piper Sandler initiated coverage on Cano Health Inc CANO with a Neutral rating. The price target for Cano Health is set to $11.00. Cano Health earned $0.03 in the second quarter. The stock has a 52-week-high of $16.17 and a 52-week-low of $9.20. At the end of the last trading period, Cano Health closed at $11.10.

Truist Securities initiated coverage on Celularity Inc CELU with a Buy rating. The price target for Celularity is set to $12.00. The current stock performance of Celularity shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $7.33.

HC Wainwright & Co. initiated coverage on ToughBuilt Industries Inc TBLT with a Buy rating. The price target for ToughBuilt Industries is set to $1.50. In the second quarter, ToughBuilt Industries showed an EPS of $0.09, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $1.78 and a 52-week-low of $0.46. At the end of the last trading period, ToughBuilt Industries closed at $0.50.

Cowen & Co. initiated coverage on Arbe Robotics Ltd ARBE with an Outperform rating. The price target for Arbe Robotics is set to $12.00. The current stock performance of Arbe Robotics shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $8.22.

SVB Leerink initiated coverage on Beam Therapeutics Inc BEAM with an Outperform rating. The price target for Beam Therapeutics is set to $117.00. For the second quarter, Beam Therapeutics had an EPS of $1.23, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of $138.52 and a 52-week-low of $29.43. Beam Therapeutics closed at $90.71 at the end of the last trading period.

With an Outperform rating, Cowen & Co. initiated coverage on Cue Health Inc HLTH. The price target seems to have been set at $14.00 for Cue Health. In the second quarter, Cue Health showed an EPS of $0.03, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Cue Health closed at $9.95 at the end of the last trading period.

With a Buy rating, Berenberg initiated coverage on Penn National Gaming Inc PENN. The price target seems to have been set at $95.00 for Penn National Gaming. For the second quarter, Penn National Gaming had an EPS of $1.17, compared to year-ago quarter EPS of $1.69. At the moment, the stock has a 52-week-high of $142.00 and a 52-week-low of $52.09. Penn National Gaming closed at $77.30 at the end of the last trading period.

With a Buy rating, Berenberg initiated coverage on Scientific Games Corp SGMS. The price target seems to have been set at $98.00 for Scientific Games. In the second quarter, Scientific Games showed an EPS of $1.10, compared to $2.15 from the year-ago quarter. The stock has a 52-week-high of $89.16 and a 52-week-low of $30.11. At the end of the last trading period, Scientific Games closed at $85.26.

Berenberg initiated coverage on International Game Technology PLC IGT with a Buy rating. The price target for Intl Game Tech is set to $35.00. Intl Game Tech earned $0.48 in the second quarter, compared to $0.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.30 and a 52-week-low of $7.68. Intl Game Tech closed at $29.07 at the end of the last trading period.

With a Market Perform rating, SVB Leerink initiated coverage on Editas Medicine Inc EDIT. The price target seems to have been set at $41.00 for Editas Medicine. For the second quarter, Editas Medicine had an EPS of $0.81, compared to year-ago quarter EPS of $0.43. The current stock performance of Editas Medicine shows a 52-week-high of $99.95 and a 52-week-low of $27.12. Moreover, at the end of the last trading period, the closing price was at $38.28.

HC Wainwright & Co. initiated coverage on Landos Biopharma Inc LABP with a Buy rating. The price target for Landos Biopharma is set to $50.00. Interestingly, in the second quarter, Landos Biopharma's EPS was $0.12. The current stock performance of Landos Biopharma shows a 52-week-high of $16.99 and a 52-week-low of $8.82. Moreover, at the end of the last trading period, the closing price was at $14.66.

With an Outperform rating, SVB Leerink initiated coverage on CRISPR Therapeutics AG CRSP. The price target seems to have been set at $126.00 for CRISPR Therapeutics. For the second quarter, CRISPR Therapeutics had an EPS of $9.44, compared to year-ago quarter EPS of $1.30. The stock has a 52-week-high of $220.20 and a 52-week-low of $84.38. At the end of the last trading period, CRISPR Therapeutics closed at $96.21.

With an Overweight rating, JP Morgan initiated coverage on Clearwater Analytics Holdings Inc CWAN. The price target seems to have been set at $31.00 for Clearwater Analytics Hldg. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Clearwater Analytics Hldg closed at $25.11.

RBC Capital initiated coverage on Clearwater Analytics Holdings Inc CWAN with an Outperform rating. The price target for Clearwater Analytics Hldg is set to $29.00. The current stock performance of Clearwater Analytics Hldg shows a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Moreover, at the end of the last trading period, the closing price was at $25.11.

Oppenheimer initiated coverage on Academy Sports and Outdoors Inc ASO with an Outperform rating. The price target for Academy Sports is set to $50.00. Academy Sports earned $2.34 in the second quarter, compared to $1.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.65 and a 52-week-low of $13.57. Academy Sports closed at $41.23 at the end of the last trading period.

With a Hold rating, Stifel initiated coverage on Blink Charging Co BLNK. The price target seems to have been set at $29.00 for Blink Charging. For the second quarter, Blink Charging had an EPS of $0.32, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $64.50 and a 52-week-low of $7.33. At the end of the last trading period, Blink Charging closed at $28.79.

Wells Fargo initiated coverage on Teladoc Health Inc TDOC with an Overweight rating. The price target for Teladoc Health is set to $156.00. Teladoc Health earned $0.86 in the second quarter, compared to $0.34 in the year-ago quarter. The stock has a 52-week-high of $308.00 and a 52-week-low of $120.67. At the end of the last trading period, Teladoc Health closed at $136.21.

Piper Sandler initiated coverage on Clearwater Analytics Holdings Inc CWAN with a Neutral rating. The price target for Clearwater Analytics Hldg is set to $25.00. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Clearwater Analytics Hldg closed at $25.11.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...